History
  • No items yet
midpage
Richard (Rickey) Palermo v. LifeLink Foundation, Inc.
152 So. 3d 1099
Miss.
2014
Read the full case

Background

  • In 2005 Richard Palermo received a tibialis allograft from LifeLink during ACL/meniscus surgery and later developed a post‑operative infection; the graft later tested negative for bacteria.
  • Palermo sued LifeLink (among others) alleging strict products liability, negligence, and breach of warranty under the Mississippi Products Liability Act (MPLA), Miss. Code § 11‑1‑63.
  • LifeLink moved for summary judgment arguing it is a service provider under Miss. Code § 41‑41‑1 (the "blood/tissue shield" statute) and therefore not subject to the MPLA.
  • The trial court granted summary judgment for LifeLink; the Court of Appeals affirmed, holding human tissue distribution is not a "sale" and is excluded from products‑liability law.
  • The Mississippi Supreme Court granted certiorari limited to whether the MPLA applies to human tissue in light of § 41‑41‑1 and affirmed the lower courts.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the MPLA (strict products liability) applies to human tissue/allografts Palermo: MPLA applies; § 41‑41‑1 does not bar products‑liability claims for contaminated human tissue LifeLink: § 41‑41‑1 defines procurement/processing/distribution/use of human tissue as a "service" and not a "sale," so MPLA (which covers "manufacturers"/"sellers") does not apply Held: MPLA does not apply to human tissue providers statutorily defined as service providers under § 41‑41‑1; summary judgment affirmed
Whether § 41‑41‑1 should be read as an exception to § 11‑1‑63 or vice versa Palermo: MPLA controls; § 41‑41‑1 irrelevant to products liability scheme LifeLink: Historical context and statutory language ("for all purposes whatsoever") show legislature intended to treat blood/tissue as services, exempting them from products liability Held: § 41‑41‑1 predates and excludes persons covered from strict products liability; MPLA’s terms (manufacturer/seller) do not reach service providers
Whether there were genuine factual disputes (contamination/causation) precluding summary judgment Palermo: Disputed facts about whether the allograft was contaminated and whether LifeLink’s conduct caused infection LifeLink: Even accepting factual disputes, it is not subject to MPLA; negligence claim also failed on elements Held: On MPLA claim, no need to reach factual disputes because statute removes claim; trial court also correctly found negligence/causation not proven for summary judgment

Key Cases Cited

  • State Stove Mfg. Co. v. Hodges, 189 So. 2d 113 (Miss. 1966) (adopted strict products‑liability principles and tied strict liability to the existence of a sale)
  • Lawson v. Honeywell Intern., Inc., 75 So. 3d 1024 (Miss. 2011) (statutory interpretation principles; definition of "manufacturer" for products‑liability purposes)
  • Seymour v. Brunswick Corp., 655 So. 2d 892 (Miss. 1995) (de novo review standard for summary judgment)
  • Huff v. Shopsmith, Inc., 786 So. 2d 383 (Miss. 2001) (common law remains influential in products‑liability statutory scheme)
  • Williams v. Bennett, 921 So. 2d 1269 (Miss. 2006) (statutory products‑liability scheme reflects common law tenor)
  • Scordino v. Hopeman Bros., Inc., 662 So. 2d 640 (Miss. 1995) (definition of "manufacturer" in Mississippi products‑liability context)
Read the full case

Case Details

Case Name: Richard (Rickey) Palermo v. LifeLink Foundation, Inc.
Court Name: Mississippi Supreme Court
Date Published: Nov 20, 2014
Citation: 152 So. 3d 1099
Docket Number: 2012-CT-01228-SCT
Court Abbreviation: Miss.